Log in to save to my catalogue

Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders

Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4700059

Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders

About this item

Full title

Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders

Publisher

Cham: Springer International Publishing

Journal title

Drugs (New York, N.Y.), 2016-01, Vol.76 (1), p.1-12

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Cardiovascular and metabolic disorders, such as hypertension, insulin resistance, dyslipidemia or obesity are linked with chronic low-grade inflammation and dysregulation of the renin–angiotensin system (RAS). Consequently, RAS inhibition by ACE inhibitors or angiotensin AT1 receptor (AT1R) blockers is the evidence-based standard for cardiovascular...

Alternative Titles

Full title

Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4700059

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4700059

Other Identifiers

ISSN

0012-6667,1179-1950

E-ISSN

1179-1950

DOI

10.1007/s40265-015-0509-4

How to access this item